EFFECT OF MIRIKIZUMAB ON CLINICAL AND ENDOSCOPIC OUTCOMES BASED ON PRIOR ADVANCED THERAPY FAILURE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Seyedehsan Navabi  1     Geert R. D'Haens  2     Karen Samaan  3     Xingyuan Li  3     Vipin Arora  3     Isabel Redondo  3     Silvio Danese  4    
1 Rutgers New Jersey Medical School, Newark, United States
2 Amsterdam University Medical Centers, Amsterdam, Netherlands
3 Eli Lilly and Company, Indianapolis, United States
4 IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy

Topic
Endoscopy, Histopathology, IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing